BRIEF-Zogenix says FDA granted ZX008 orphan drug designation for LGS
June 22, 2017 at 07:42 AM EDT
* Zogenix Inc - on June 22 U.S. FDA granted its investigational drug, ZX008 orphan drug designation for treatment of Lennox Gastaut Syndrome
